There are several types of breast cancer with different hormone receptors. Some breast cancer types have well-established treatment plans that have proven to work well for many breast cancer patients. However, there is always room for improvement when it comes to breast cancer treatment options. One area of focus for breast cancer research is looking at possible new combinations of therapies and treatment plans using FDA approved medicines and procedures.
Some types of breast cancer have fewer well-defined treatment options including triple negative breast cancer. In this case, cancer research may be looking at new potential treatment options.
Maryland Oncology Hematology participates in breast cancer research, along with The US Oncology Network, in hopes of being able to find and provide new treatments to our patients. Breast cancer research trials are now available at six Maryland Oncology Hematology locations - including Bethesda, Rockville, Wheaton, Silver Spring, and Columbia. This research brings new hope for breast cancer patients, for a new treatment option, and renewed hope for life.
To understand more about the clinical trial process, read our Understanding Clinical Trials page.
Available Breast Cancer Research Trials
Before a new breast cancer treatment is introduced to patients across the country, certain FDA (Federal Drug Administration) requirements must be met to show that the cancer treatment is effective and safe, and to determine the right amount and timing of the doses.
If the new cancer treatment can be proven safe and effective for the types of patients the trial has targeted then the FDA will be able to approve it for use among all patients in the U.S. with the same type of cancer.
Is a Breast Cancer Clinical Trial Right for Me?
If your oncologist thinks you would be a good fit for one of the breast cancer research trials they will ask you to meet with a clinical research nurse at one of the designated clinical trial locations to review the trial’s selection criteria, which vary for each researched treatment.
Treatments being researched by the breast cancer specialists at Maryland Oncology Hematology have already been proven safe for humans. However, every patient that volunteers to participate in a breast cancer trial is carefully monitored by our cancer research specialists at our offices to determine the effectiveness of the treatment. They will also carefully monitor each trial participant for side effects. If they find that a treatment isn’t working for a patient on a clinical trial the research team will meet to determine if a different treatment option is available that has potential to be more effective.
It’s our hope that the clinical trial results will make a helpful impact and then ultimately provide new, successful, FDA-approved treatment options for breast cancer.
As a member of US Oncology Research, Maryland Oncology Hematology is involved with many clinical trials in Maryland and the Washington D.C. area. At any given time, we have many active clinical trials; not only for breast cancer, but also for lung cancer, prostate cancer, ovarian cancer, Lymphoma, and many more. Continuing to provide our community with access to promising new therapies is one of our top priorities.
For more information on participating in a research trial or if you would like to learn more about our other clinical trials, please ask your oncologist. A complete list of all of the trials available through Maryland Oncology Hematology can be seen at http://marylandoncology.com/treatments-services/clinical-trials-research/available-trials/